Evidence for the involvement of nitric oxide and nitric oxide synthase in the modulation of opioid-induced antinociception and the inhibitory effects of exposure to 60-Hz magnetic fields in the land snail

Brain Research

Volumn 809, Issue 1, 1998, Pages 50-57

  Kavaliers, M ^a   Choleris, E ^b   Prato, F S ^b   Ossenkopp, K P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

60 Hz; Antinociception; ELF magnetic field; Nitric oxide; Nitric oxide synthase

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; MEMBRANE METALLOENDOPEPTIDASE; N [1 [(2,2 DIMETHYL 1,3 DIOXOLAN 4 YL)METHOXYCARBONYL] 2 PHENYLETHYL]PHENYLALANYL BETA ALANINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; MAGNETIC FIELD; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SNAIL;

ANIMALS; DIOXOLANES; DIPEPTIDES; ELECTROMAGNETIC FIELDS; ENZYME INHIBITORS; NERVOUS SYSTEM; NEURAL INHIBITION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOCICEPTORS; PENICILLAMINE; PROTEASE INHIBITORS; S-NITROSO-N-ACETYLPENICILLAMINE; SNAILS;

EID: 0032569697     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00844-0     Document Type: Article

References (49)

1. Adair R.K. Constraints on biological effects of weak extremely low frequency electromagnetic fields. Physiol. Rev. A. 43:1991;449-473.
2. G-nitro-arginine methyl ester. Life Sci. 52:1993;245-249.
3. G-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse. Neuroreport. 4:1993;307-312.
4. Bhargava H.N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26:1995;1049-1053.
5. Bawin S.M., Satmary W.M., Jones R.A., Adey W.R., Zimmerman G. Extremely-low-frequency magnetic fields disrupt rhythmic slow activity in rat hippocampal slices. Bioelectromagnetics. 17:1996;388-395.
6. Betancur C., Dell'Omo, Allera E. Magnetic field effects on stress-induced analgesia in mice: modulation of light. Neurosci. Lett. 182:1994;147-150.
7. Bret D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
8. Brocklehurst B., McLauchlan K.A. Free radical mechanism for the effects of environmental electromagnetic fields on biological systems. Int. J. Radiat. Biol. 69:1996;3-24.
9. Chipkin R.E., Berger J.G., Billard W., Iorio L.C., Chapman R., Barnett A. Pharmacology of SCH34826, an orally active enkephalinase inhibitor analgesic. J. Pharmacol. Exp. Ther. 245:1988;829-838.
10. Choleris E., Kavaliers M., Prato F.S., Ossenkopp K.-P. Evidence for nitric oxide involvement in the mediation of the inhibitory effects of 60 Hz magnetic fields on opioid-induced analgesia in the land snail. Bioelectromagnetics Society Abstract. 20:1998;208-209.
11. Del Seppia C., Ghione S., Luschi P., Papi F. Exposure to oscillating magnetic fields influences sensitivity to electrical stimuli: I. Experiments on pigeons. Bioelectromagnetics. 16:1995;290-294.
12. Dyakonova V., Carlberg M., Sakharov D., Elofsson R. Anatomical basis for interactions of enkephalins with other transmitters in the CNS of a snail. J. Comp. Neurol. 361:1995;38-47.
13. Elofsson R., Carlberg M., Moroz L., Nezlin L., Sakharov D. Is nitric oxide (NO) produced by invertebrate neurones? Neuroreport. 4:1993;279-282.
14. Elphick M.R., Kemenes G., Staras K., O'Shea M. Behavioral role for nitric oxide in chemosensory activation of feeding in a mollusc. J. Neurosci. 15:1995;7653-7664.
15. Granados-Soto V., Rufino M., Lopes L.D.G., Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340:1997;177-180.
16. Kavaliers M. Evolutionary and comparative aspects of nociception. Brain Res. Bull. 21:1988;923-931.
17. Kavaliers M., Ossenkopp K.-P. Calcium channel involvement in magnetic field inhibition of morphine-induced analgesia. Naunyn-Schmiedbergs Arch. Pharmacol. 336:1987;308-315.
18. Kavaliers M., Ossenkopp K.-P. Magnetic fields inhibit opioid-mediated analgesic behaviours of the terrestrial snail, Cepaea nemoralis. J. Comp. Physiol. A. 162:1988;551-558.
19. Kavaliers M., Ossenkopp K.-P. Opioid systems and magnetic field effects in the land snail, Cepaea nemoralis. Biol. Bull. 180:1991;301-309.
20. Kavaliers M., Choleris E., Saucier D.M. The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis. Peptides. 13:1997;943-947.
21. Kavaliers M., Ossenkopp K.-P., Tysdale D.M. Evidence for the involvement of protein kinase C in the modulation of morphine-induced analgesia and the inhibitory effects of exposure to 60-Hz magnetic fields in the snails, Cepaea nemoralis. Brain Res. 554:1991;65-71.
22. Kawabata A., Manane S., Manage Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112:1994;547-550.
23. Kimes A.S., Vaupel D.B., London E.D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology. 112:1993;521-524.
24. J.L. Kirschvink, M.M. Walker, Particle size considerations for magnetite-based magnetoreceptors, in: J.L. Kirschvink, D.S. Johnes, B.J. MacFadden, (Eds.), Magnetite Biomineralization and Magnetoreception in Organisms: A New Biomagnetism, Plenum, New York, 1985, pp. 243-256.
25. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148:1992;1-5.
26. Kolesnikov Y.A., Pan Y.-X., Babey A.-M., Jain S., Wilosn R., Pasternak G.A. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. USA. 94:1997;8220-8225.
27. Lednev V.V. Possible mechanisms for the influence of weak magnetic fields on biological systems. Bioelectromagnetics. 12:1991;71-75.
28. Lednev V.V. Bioeffects of weak combined static and alternating magnetic fields. Biofzika. 41:1996;224-232.
29. Machelska H., Labuz D., Przewlocki R., Przewlocki B. Inhibition of nitric oxide synthase enhance antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J. Pharmacol. Exp. Ther. 282:1997;977-984.
30. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenin in the rat. Neuroscience. 60:1994;367-374.
31. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble gunaylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214:1994;93-96.
32. Mitsuhiko M., Takayama K., Okada J. Increase in nitric oxide and cyclic GMP of rat cerebellum by radio frequency burst-type electromagnetic field radiation. J. Physiol. 461:1993;513-524.
33. G-Nitro-L-arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
34. Moroz L.L., Winlow W., Turner R.W., Bulloch A.G.M., Lukowiak K., Syed N.I. Nitric oxide synthase-immunoreactive cells in the CNS and periphery of Lymnaea. Neuroreport. 5:1994;1277-1280.
35. Nathan C., Xie Q.-W. Nitric oxide synthase: roles, tolls and control. Cell. 78:1994;915-918.
36. Ossenkopp K.-P., Kavaliers M. Morphine-induced analgesia and exposure to 60 Hz magnetic fields: inhibition of nocturnal analgesia is a function of magnetic field intensity. Brain Res. 418:1987;356-360.
37. Papi F., Luschi P., Limonta P. Orientation-disturbing magnetic treatment affects the pigeon opioid systems. J. Exp. Biol. 166:1992;169-179.
38. Papi F., Ghione S., Rosa C., Del Seppia C., Luschi P. Exposure to oscillating magnetic fields influences sensitivity to electrical stimuli: experiments on humans. Bioelectromagnetics. 16:1995;295-300.
39. Prato F.S., Carson J.J.L., Ossenkopp K.-P., Kavaliers M. Possible mechanisms by which extremely low frequency magnetic fields affect opioid function. FASEB J. 9:1995;807-814.
40. Prato F.S., Kavaliers M., Carson J.J.L. Behavioural evidence that magnetic field effects in the land snail, Cepaea nemoralis, might not depend on magnetite or induced electric currents. Bioelectromagnetics. 17:1996;123-130.
41. Prato F.S., Kavaliers M., Cullen A.P., Thomas A.W. Light-dependent and -independent behavioral effects of extremely low frequency magnetic fields in land snails are consistent with a parametric resonance mechanism. Bioelectromagnetics. 18:1997;284-291.
42. Prato F.S., Kavaliers M. Modulatory effects of light on nitric oxide associated inhibitory effects of extremely low frequency magnetic fields on opioid-induced analgesia in the land snail. Bioelectromagnetics Society Abstracts. 20:1998;60-61.
43. Przewlocki R., Machelska H., Przewlocki B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life. Sci. 53:1993;PL1-PL5.
44. Robertson J.D., Bonaventura J., Kohm A. Nitric oxide synthase inhibition blocks octopus touch learning without producing sensory or motor dysfunction. Proc. R. Soc. London B. 261:1995;167-172.
45. Saksida L.M., Galea L.A.M., Kavaliers M. Antinociceptive effects of the enkephalinase inhibitor SCH34826 in the snail, Cepaea nemoralis. Peptides. 14:1993;763-768.
46. Sartuci F., Bonfiglio L., Del Seppia C., Luschi P., Ghione S., Murri L., Papi F. Changes in pain perception and pain-related somatosensory evoked potentials in humans produced by exposure to oscillating magnetic fields. Brain Res. 769:1997;362-366.
47. V.K. Skukla, S. Lemaire, Nonopioid effects of dynorphins: possible role of NMDA receptor, Trends Pharmacol. Sci. 15, 420-424.
48. Xu J.Y., Pieper G.M., Tseng L.F. Activation of a NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse. Pain. 63:1995;377-383.
49. Xu J.Y., Hill K.P., Bidlack The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J. Pharmacol. Exp. Ther. 284:1998;196-201.